Recent Articles
Ksana Health 2022 Highlights (in Video)
For Ksana Health, 2022 was a year of perseverance, learning and optimization. We are grateful to all the partners, collaborators and supporters who made the year what it was. The video below...
Continue readingStudy Result: The TAG Study (McNeilly, 2023) further confirms link between teen mood and social media communications.
We are glad to share this recent publication of the Transitions in Adolescent Girls (TAG) Study (McNeilly, 2023), a longitudinal study examining the extent to which daily mood is associated with digital...
Continue readingKsana Health Achieves SOC2 Type 2 Compliance for HIPAA and GDPR
Ksana Health completed its first third-party assessment for security and privacy controls, receiving unqualified approval attesting to the strength of our controls and compliance with best practices and statutory requirements, including: AICPA,...
Continue readingKsana Health Founder weighs in on Psychedelics & Technology
Palo Santo, a venture fund focused on psychedelic therapeutics and a Ksana Health investor, took a survey of the perspectives of a number of thought leaders in the psychedelics space in light...
Continue readingPodcast Alert: Novo Nordisk’s Business Innovation Garage speaks to the value of Partnering with Innovative Startups
Recently Ksana Health was highlighted in an interview with Matt Dugan, Head of Business Innovation Garage at Global IT, Novo Nordisk. Kim Stensdal of The Danish IT Society conducted this interview on...
Continue readingKsana Health partners with Beckley PsyTech!
At Ksana Health, we provide our continuous behavior measurement platform (CBHM), Effortless Assessment of Risk States (EARS), to clinical researchers. This platform has given them richer insight into the passive behavior of...
Continue readingKsana Health at SXSW 2022
Trip Planning: Psychedelics and Digital Therapies March 16, 2022 · 11:30 a.m. Ksana Health’s CEO and Co-Founder Dr. Nick Allen is participating in a panel discussion on recent innovations in mental health...
Continue readingKsana Health Joins Novo Nordisk’s Global Prevention Accelerator
Pilot Program Leverages Continuous Objective Measurement to Identify and Address Aspects of Behavior Related to Improved Health Outcomes Ksana Health has been selected by Novo Nordisk’s Global Prevention Accelerator to apply continuous...
Continue readingKsana Health and NatureQuant Announce Strategic Partnership To Accelerate the Objective Measurement of Nature on Mental Health
The answer to the pandemic’s significant effect on mental health may be spending more time in nature. Our partnership with NatureQuant allows for objective measurement of ecotherapy. Press release: Digital Behavioral Health Innovator...
Continue readingIntroducing EARS 2.0
Ksana Health is pleased to announce new 2.0 improvements to the Effortless Assessment Research System (EARS). Mobile sensing and passive remote assessment enabled by EARS is a new standard in behavioral research...
Continue reading